10-K Filing

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC CIK: 1730430 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001558370-22-001932`
Period End Date	20211231
Filing Date	20220224
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	knsa-20211231x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 55 Income Statement 51 Cash Flow Statement 82 Stockholders Equity 22

Balance Sheet 55 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$122.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$114.04M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$209.44M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$59.73M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$210.00K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.98M	USD	Point-in-time
Inventory	`InventoryNet`	$3.67M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.56M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.58M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$196.45M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$333.25M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.05M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.83M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$6.57M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$5.55M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$8.72M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$5.59M	USD	Point-in-time
Intangible asset, net	`FiniteLivedIntangibleAssetsNet`	$20.00M	USD	Point-in-time
Intangible asset, net	`FiniteLivedIntangibleAssetsNet`	$19.25M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$10.00K	USD	Point-in-time
Total assets	`Assets`	$232.80M	USD	Point-in-time
Total assets	`Assets`	$349.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$503.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$29.20M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$38.03M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.38M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.11M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.54M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$37.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$44.82M	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.67M	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$4.88M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$805.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$270.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$37.53M	USD	Point-in-time
Total liabilities	`Liabilities`	$47.76M	USD	Point-in-time
Commitments and contingencies (Note 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$860.48M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$829.42M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-34.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-66.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-517.47M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-675.40M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$225.42M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$311.94M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$279.27M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$185.04M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$349.46M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$232.80M	USD	Point-in-time

Income Statement 51 line items

Line Item	Tag	Value	Unit	Period
Product revenue, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$38.54M	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$9.10M	USD	Annual
Collaboration expenses	`RoyaltyExpense`	$835.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$99.30M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$112.04M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$135.00M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$85.95M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$34.96M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$45.32M	USD	Annual
Total operating expenses	`TotalCostOfRevenueAndOperatingExpenses`	$169.96M	USD	Annual
Total operating expenses	`TotalCostOfRevenueAndOperatingExpenses`	$157.36M	USD	Annual
Total operating expenses	`TotalCostOfRevenueAndOperatingExpenses`	$195.18M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-156.64M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-157.36M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-169.96M	USD	Annual
Interest income (expense)	`InvestmentIncomeInterest`	$97.00K	USD	Annual
Interest income (expense)	`InvestmentIncomeInterest`	$6.05M	USD	Annual
Interest income (expense)	`InvestmentIncomeInterest`	$1.13M	USD	Annual
Loss before benefit (provision) for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-156.54M	USD	Annual
Loss before benefit (provision) for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-156.23M	USD	Annual
Loss before benefit (provision) for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-163.91M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.39M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$-2.05M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.15M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.92M	USD	Annual
Net loss	`NetIncomeLoss`	$-161.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-161.38M	USD	Annual
Net loss per share attributable to common shareholders-basic	`EarningsPerShareBasic`	$-2.61	USD	Annual
Net loss per share attributable to common shareholders-basic	`EarningsPerShareBasic`	$-2.30	USD	Annual
Net loss per share attributable to common shareholders-basic	`EarningsPerShareBasic`	$-2.99	USD	Annual
Net loss per share attributable to common shareholders-diluted	`EarningsPerShareDiluted`	$-2.30	USD	Annual
Net loss per share attributable to common shareholders-diluted	`EarningsPerShareDiluted`	$-2.61	USD	Annual
Net loss per share attributable to common shareholders-diluted	`EarningsPerShareDiluted`	$-2.99	USD	Annual
Weighted average common shares outstanding-basic	`WeightedAverageNumberOfSharesOutstandingBasic`	68.58M	shares	Annual
Weighted average common shares outstanding-basic	`WeightedAverageNumberOfSharesOutstandingBasic`	61.84M	shares	Annual
Weighted average common shares outstanding-basic	`WeightedAverageNumberOfSharesOutstandingBasic`	54.05M	shares	Annual
Weighted average common shares outstanding-diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.58M	shares	Annual
Weighted average common shares outstanding-diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.05M	shares	Annual
Weighted average common shares outstanding-diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	61.84M	shares	Annual
Net loss	`NetIncomeLoss`	$-161.38M	USD	Annual
Net loss	`NetIncomeLoss`	$-161.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.92M	USD	Annual
Unrealized loss on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-32.00K	USD	Annual
Unrealized loss on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-67.00K	USD	Annual
Unrealized loss on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$37.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-32.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$37.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-67.00K	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-161.83M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-161.45M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-157.96M	USD	Annual

Cash Flow Statement 82 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-161.87M	USD	Annual
Net loss	`ProfitLoss`	$-161.38M	USD	Annual
Net loss	`ProfitLoss`	$-157.92M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$2.35M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$2.40M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$2.07M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$20.88M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$15.08M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$25.17M	USD	Annual
Class A common shares issued or to be issued as consideration for Primatope, including milestone payments	`IssuanceOfStockForAcquisition`	$8.80M	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-103.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-21.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$1.21M	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$2.63M	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$1.40M	USD	Annual
Amortization (accretion) of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-123.00K	USD	Annual
Amortization (accretion) of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$3.50M	USD	Annual
Amortization (accretion) of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-664.00K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$11.00K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-3.16M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$4.36M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.94M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.02M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.33M	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$3.91M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$3.67M	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$5.59M	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$3.28M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.71M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.37M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.97M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$10.34M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$4.64M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$8.80M	USD	Annual
Accrued milestones	`IncreaseDecreaseInAccruedMilestone`	$-15.00M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-1.70M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-2.55M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-1.26M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-535.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$326.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$478.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-136.53M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-158.37M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-126.30M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$415.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.20M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$283.00K	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$488.77M	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$157.25M	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$430.21M	USD	Annual
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$306.30M	USD	Annual
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$407.05M	USD	Annual
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$541.19M	USD	Annual
Intangible asset acquired	`PaymentsToAcquireIntangibleAssets`	$20.00M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-23.44M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$49.21M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$128.63M	USD	Annual
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$118.00K	USD	Annual
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$1.14M	USD	Annual
Proceeds from issuance of Class A common shares under incentive award plans and employee share purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$1.12M	USD	Annual
Proceeds from issuance of Class A common shares under incentive award plans and employee share purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$6.55M	USD	Annual
Proceeds from issuance of Class A common shares under incentive award plans and employee share purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$5.88M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.88M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$84.11M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$227.09M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-25.05M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$8.22M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$67.11M	USD	Annual
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$122.47M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.25M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.14M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.25M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.14M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$122.47M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaidNet`	$482.00K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$1.72M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$1.28M	USD	Annual
Right-of-use asset obtained in exchange for operating lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.62M	USD	Annual
Right-of-use asset obtained in exchange for operating lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$6.04M	USD	Annual
Property and equipment included in accrued expenses and accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$222.00K	USD	Annual

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of the period	`StockholdersEquity`	$225.42M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$311.94M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$185.04M	USD	Point-in-time
Common shares issued or to be issued in connection with the acquisition of all issued and outstanding equity securities of Primatope Therapeutics, Inc.	`StockIssuedDuringPeriodValueAcquisitions`	$7.00M	USD	Annual
Common shares issued or to be issued in connection with a milestone payment due to Primatope Therapeutics, Inc.	`StockIssuedDuringPeriodValueMilestonePayments`	$1.80M	USD	Annual
Issuance of Class A shares under incentive award plans and employee share purchase plan	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$1.12M	USD	Annual
Issuance of Class A shares under incentive award plans and employee share purchase plan	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$6.55M	USD	Annual
Issuance of Class A shares under incentive award plans and employee share purchase plan	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$5.88M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.88M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$25.17M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.08M	USD	Annual
Unrealized loss on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-32.00K	USD	Annual
Unrealized loss on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-67.00K	USD	Annual
Unrealized loss on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$37.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-161.38M	USD	Annual
Net loss	`NetIncomeLoss`	$-161.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.92M	USD	Annual
Balance at the end of the period	`StockholdersEquity`	$225.42M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$311.94M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$185.04M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.